Acessibilidade / Reportar erro
This document comments:

Comment on “Factors affecting the clinical outcomes in pediatric post-cardiotomy patients requiring perioperative peritoneal dialysis”

Dear Editor,

In a retrospective article entitled “Factors affecting the clinical outcomes in pediatric post-cardiotomy patients requiring perioperative peritoneal dialysis,” the authors investigated factors associated with mortality in pediatric patients undergoing perioperative peritoneal dialysis after cardiotomy11 Arslan AH, Aksoy T, Ugur M, Ustunsoy H. Factors affecting the clinical outcomes in pediatric post-cardiotomy patients requiring perioperative peritoneal dialysis. Rev Assoc Med Bras (1992). 2022;68(5):627-31. https://doi.org/10.1590/1806-9282.20211279
https://doi.org/10.1590/1806-9282.202112...
. In this study, the authors found that younger preoperative age, longer cardiopulmonary bypass time, prolonged intubation, prolonged inotropic support, and need for extracorporeal membrane oxygenation were associated with a higher risk of mortality. In our opinion, although the findings of this study are of great value, there are some issues that need to be addressed.

First, some continuous variables were not properly expressed. As described in Table 1, the age of the included patients was 11.7±37.6 months. As a result, the standard deviation (37.6) is significantly larger than the mean (11.7), indicating that age is a skewed distribution variable and it should be described as median and interquartile range, not as mean±standard deviation. Similarly, the variables such as weight and preoperative PaO2 should also be appropriately described as median and interquartile range.

Second, this study did not describe which statistical method was used to screen for risk factors associated with mortality. Providing detailed statistical methods will help improve the reliability and reproducibility of this study. Furthermore, although preoperative lower age is shown to be a risk factor for mortality in this study, the definition of preoperative lower age is unknown. We are curious about this: less than 6 months or 12 months? Evidence from a pediatric cardiac intensive care unit indicated that the age of patient less than 1 month was associated with a higher risk of mortality22 Morris MC, Ittenbach RF, Godinez RI, Portnoy JD, Tabbutt S, Hanna BD, et al. Risk factors for mortality in 137 pediatric cardiac intensive care unit patients managed with extracorporeal membrane oxygenation. Crit Care Med. 2004;32(4):1061-9. https://doi.org/10.1097/01.ccm.0000119425.04364.cf
https://doi.org/10.1097/01.ccm.000011942...
. Thus, we believe that providing a precise definition of younger preoperative age is helpful for clinicians to give individualized treatment strategies for children undergoing cardiac surgery.

Third, more information after cardiac surgery is unknown. In such case, it is suspected that patients who die may have more red blood cell transfusion and use of vasoactive agents after cardiac surgery. Results from a previous study suggested that red blood cell transfusion was independently associated with a higher risk of mortality in critically ill children33 Kneyber MC, Hersi MI, Twisk JW, Markhorst DG, Plötz FB. Red blood cell transfusion in critically ill children is independently associated with increased mortality. Intensive Care Med. 2007;33(8):1414-22. https://doi.org/10.1007/s00134-007-0741-9
https://doi.org/10.1007/s00134-007-0741-...
. Another study44 Loomba RS, Flores S. Use of vasoactive agents in postoperative pediatric cardiac patients: insights from a national database. Congenit Heart Dis. 2019;14(6):1176-84. https://doi.org/10.1111/chd.12837
https://doi.org/10.1111/chd.12837...
involving 43,441 postoperative pediatric cardiac patients displayed that the use of milrinone alone was associated with a lower risk of in-hospital mortality, while the use of all other vasoactive agents increased the risk of in-hospital mortality at least in one of the subsets. Therefore, it is necessary to provide more information after cardiac surgery (e.g., red blood cell transfusion and the use of vasoactive agents).

  • Funding: none.

REFERENCES

  • 1
    Arslan AH, Aksoy T, Ugur M, Ustunsoy H. Factors affecting the clinical outcomes in pediatric post-cardiotomy patients requiring perioperative peritoneal dialysis. Rev Assoc Med Bras (1992). 2022;68(5):627-31. https://doi.org/10.1590/1806-9282.20211279
    » https://doi.org/10.1590/1806-9282.20211279
  • 2
    Morris MC, Ittenbach RF, Godinez RI, Portnoy JD, Tabbutt S, Hanna BD, et al. Risk factors for mortality in 137 pediatric cardiac intensive care unit patients managed with extracorporeal membrane oxygenation. Crit Care Med. 2004;32(4):1061-9. https://doi.org/10.1097/01.ccm.0000119425.04364.cf
    » https://doi.org/10.1097/01.ccm.0000119425.04364.cf
  • 3
    Kneyber MC, Hersi MI, Twisk JW, Markhorst DG, Plötz FB. Red blood cell transfusion in critically ill children is independently associated with increased mortality. Intensive Care Med. 2007;33(8):1414-22. https://doi.org/10.1007/s00134-007-0741-9
    » https://doi.org/10.1007/s00134-007-0741-9
  • 4
    Loomba RS, Flores S. Use of vasoactive agents in postoperative pediatric cardiac patients: insights from a national database. Congenit Heart Dis. 2019;14(6):1176-84. https://doi.org/10.1111/chd.12837
    » https://doi.org/10.1111/chd.12837

Publication Dates

  • Publication in this collection
    10 Feb 2023
  • Date of issue
    2023

History

  • Received
    13 Oct 2022
  • Accepted
    30 Oct 2022
Associação Médica Brasileira R. São Carlos do Pinhal, 324, 01333-903 São Paulo SP - Brazil, Tel: +55 11 3178-6800, Fax: +55 11 3178-6816 - São Paulo - SP - Brazil
E-mail: ramb@amb.org.br